Metformin Orifarm

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Orifarm (Metformin Hydrochloride)

Q: What is Metformin Orifarm used for?

Metformin Orifarm is an oral biguanide medication used to improve blood‑sugar control in adults with type 2 diabetes mellitus. It may also be prescribed for prediabetes or polycystic ovary syndrome to address insulin resistance.

Q: How does Metformin Hydrochloride work?

Metformin Hydrochloride reduces hepatic glucose production by inhibiting mitochondrial complex I and enhances peripheral insulin sensitivity, allowing muscles and fat tissue to take up glucose more efficiently without increasing insulin secretion.

Q: What is the usual dose of Metformin Orifarm?

The dose of Metformin Orifarm is individualized by the prescribing clinician based on the patient’s glycaemic targets, renal function, and tolerability. The prescriber determines the appropriate strength and dosing schedule.

Q: Is Metformin Orifarm safe during pregnancy or breastfeeding?

Metformin Orifarm is classified as Pregnancy Category B, indicating no evidence of risk in animal studies and limited human data. It may be used during pregnancy if the benefit outweighs potential risk, and it is excreted in breast milk; clinicians should evaluate safety for nursing mothers.

Q: How do I order Metformin Orifarm from GNH India?

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does Metformin Orifarm compare with other antidiabetic drugs?

Compared with sulfonylureas, Metformin does not stimulate insulin release, so it carries a lower risk of hypoglycaemia. Unlike insulin, it is taken orally and helps reduce hepatic glucose output, making it a first‑line therapy for most patients with type 2 diabetes.

Q: What are the storage and handling requirements for Metformin Orifarm?

Metformin Orifarm should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Q: How is Metformin Orifarm administered?

Metformin Orifarm is taken orally, usually with meals to minimise gastrointestinal upset. Tablets should be swallowed whole with a full glass of water; they are not intended for crushing or chewing unless specifically instructed by a healthcare professional.

Q: What are the most serious risks associated with Metformin Orifarm?

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Q: Who should not use Metformin Orifarm?

Metformin Orifarm is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in those receiving radiographic contrast studies that may affect kidney function.

Metformin Hydrochloride, the active ingredient in Metformin Orifarm, is a biguanide presented as an oral tablet for oral use. It is used to lower blood glucose levels in adults with type 2 diabetes mellitus.

GNH India supplies Metformin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Orifarm Generics A/S

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Orifarm belongs to the biguanide class and is used to improve glycaemic control in disorders of glucose metabolism.

Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose by improving insulin sensitivity.
Prediabetes: may delay progression to overt diabetes by reducing hepatic glucose output.
Polycystic ovary syndrome (PCOS): helps restore ovulatory cycles by decreasing insulin resistance.

How It Works

Metformin Hydrochloride acts primarily by inhibiting mitochondrial respiratory‑chain complex I, which reduces hepatic gluconeogenesis and increases peripheral glucose uptake. It also enhances insulin receptor tyrosine kinase activity, leading to improved insulin sensitivity in muscle and adipose tissue without stimulating insulin secretion.

Side Effects

Metformin Orifarm may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

Gastro‑intestinal upset: nausea, abdominal discomfort, or loss of appetite.
Diarrhoea: watery stools occurring especially after dose initiation.
Metallic taste: transient alteration in taste perception.
Weight loss: modest reduction in body weight in some patients.

Serious or Rare Side Effects

Lactic acidosis: a rare but life‑threatening accumulation of lactate, especially in renal impairment.
Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
Hepatic dysfunction: marked elevation of liver enzymes or hepatitis.

Precautions & Warnings

Metformin Orifarm requires careful monitoring and specific safety measures before and during therapy.

Renal function assessment: avoid use in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²).
Hepatic disease caution: monitor liver enzymes in patients with existing liver disease.
Lactic acidosis risk: discontinue before any radiographic contrast studies that may affect kidney function.
Pregnancy safety: classified as Category B; use only if clearly needed.
Contraindication: do not use in patients with known hypersensitivity to metformin.
Store at room temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Metformin Orifarm can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

Alcohol: increases risk of lactic acidosis, especially with chronic intake.
Iodinated contrast agents: may precipitate acute renal failure, requiring temporary discontinuation.

Moderate Interactions (Monitor Closely)

Cimetidine: can raise metformin plasma concentrations, necessitating dose adjustment.
ACE inhibitors or ARBs: may affect renal function, requiring periodic monitoring.
Other antidiabetic agents (e.g., sulfonylureas, insulin): increase risk of hypoglycaemia, so glucose levels should be closely watched.

Frequently Asked Questions

Metformin Orifarm is an oral biguanide medication used to improve blood‑sugar control in adults with type 2 diabetes mellitus. It may also be prescribed for prediabetes or polycystic ovary syndrome to address insulin resistance.

Metformin Hydrochloride reduces hepatic glucose production by inhibiting mitochondrial complex I and enhances peripheral insulin sensitivity, allowing muscles and fat tissue to take up glucose more efficiently without increasing insulin secretion.

The dose of Metformin Orifarm is individualized by the prescribing clinician based on the patient’s glycaemic targets, renal function, and tolerability. The prescriber determines the appropriate strength and dosing schedule.

Metformin Orifarm is classified as Pregnancy Category B, indicating no evidence of risk in animal studies and limited human data. It may be used during pregnancy if the benefit outweighs potential risk, and it is excreted in breast milk; clinicians should evaluate safety for nursing mothers.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with sulfonylureas, Metformin does not stimulate insulin release, so it carries a lower risk of hypoglycaemia. Unlike insulin, it is taken orally and helps reduce hepatic glucose output, making it a first‑line therapy for most patients with type 2 diabetes.

Metformin Orifarm should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Metformin Orifarm is taken orally, usually with meals to minimise gastrointestinal upset. Tablets should be swallowed whole with a full glass of water; they are not intended for crushing or chewing unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin Orifarm is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in those receiving radiographic contrast studies that may affect kidney function.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.